Two new RSV vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world’s first approved shots against the common respiratory syncytial virus (RSV). The FDA, which typically follows the committee’s recommendations, is expected to decide on approval in May, ahead of RSV’s typical winter surge.
Source: www.cnn.com
Related posts:
2023 Ford GT Mk IV Has 800 HP and Makes for a Wild Send-Off
Former Golden State Star Tim Hardaway Elected To Basketball Hall Of Fame; ‘Run-TMC Is Now Run-HOF’
Police helicopters under attack for ‘global climate crisis’
Oakland Coliseum Authority approves Roots and Soul to play 2025 home games at stadium
Hot Wheels Legends Tour Winner Is Smokin' 1969 Volvo P1800 Gasser